- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/475 - Growth factors; Growth regulators
Patent holdings for IPC class C07K 14/475
Total number of patents in this class: 1656
10-year publication summary
114
|
129
|
119
|
119
|
155
|
145
|
139
|
108
|
95
|
34
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Acceleron Pharma Inc. | 365 |
42 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
28 |
The General Hospital Corporation | 4517 |
27 |
Amgen Inc. | 3779 |
22 |
Genentech, Inc. | 3742 |
19 |
The Brigham and Women's Hospital, Inc. | 2087 |
19 |
NGM Biopharmaceuticals, Inc. | 181 |
19 |
The Regents of the University of California | 18943 |
18 |
Modernatx, Inc. | 1181 |
16 |
Zensun (Shanghai) Science & Technology, Co., Ltd. | 53 |
16 |
Children's Medical Center Corporation | 1780 |
14 |
Centre National de La Recherche Scientifique | 9632 |
13 |
President and Fellows of Harvard College | 5792 |
13 |
Regeneron Pharmaceuticals, Inc. | 3650 |
13 |
The Johns Hopkins University | 5377 |
11 |
Northwestern University | 3112 |
11 |
Helixmith Co., Ltd. | 60 |
11 |
Novartis AG | 11238 |
10 |
HOBA Therapeutics ApS | 16 |
10 |
Silver Creek Pharmaceuticals, Inc. | 24 |
10 |
Other owners | 1314 |